SNK-860

Drugs of the Future

Volumn 21, Issue 3, 1996, Pages 261-265

  Mealy, N ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORO 2',5' DIOXOSPIRO [3,4 DIHYDRO 2H 1 BENZOPYRAN 4,4' IMIDAZOLIDINE] 2 CARBOXAMIDE; ALDOSE REDUCTASE INHIBITOR; ANTIDIABETIC AGENT; COLLAGEN; FIDARESTAT; GALACTITOL; INSULIN; SORBINIL; SORBITOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DOG; DRUG SYNTHESIS; ENZYME INHIBITION; ERYTHROCYTE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; LENS; MALE; MESANGIUM CELL; MOTOR NERVE CONDUCTION; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RAT; SCIATIC NERVE; SHORT SURVEY;

EID: 0030014970     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1996.021.03.348680     Document Type: Short Survey

References (29)

1. Yamaguchi, T., Miura, K , Usui, T., Unno, R., Matsumoto, Y., Fukushima, M , Mizuno, K., Kondo, Y., Baba, Y., Kurono, M. Synthesis and aldose reductase inhibitory activity of 2-substituted - 6-fluoro - 2,3 - dihydrospiro[4H - 1 - benzopyran - 4,4′ - imidazolidine]-2′,5′-diones Arzneim-Forsch-Drug Res 1994, 44: 344-8.
2. Kurono, M., Kondo, Y., Yamaguchi, T.et al. (Sanwa Kagaku Kenkyusho Co., Ltd.). Hydantoin derivs, for treating complications of diabetes. EP 264586, JP 88057588, JP 88126881, JP 88250373, US 4861792, US 4978758, US 5447946.
3. Prous, J.R. Treatment of diabetic complications. In: The Year's Drug News - Therapeutic Targets, 1994 Edition, Prous Science Publishers, Barcelona, 1994, 275-9.
4. Mizuno, K., Yamaguchi, T., Inoue, A. et al. Profile of a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro-[chroman-4,4′-imidazolidine] -2-carboxamide (SNK-860). Int Cong Ser-Excerpta Med 1990, 913: 89-96.
5. Kawamura, T., Suzuki, K., Matsumae, H., Sano, T., Sakamoto, N , Hotta, N. Effects of glucose and SNK-860, an aldose reductase inhibitor, on the polyol pathway and chemiluminescence response of human neutrophils in vitro. Diabetic Med 1995, 12: 392-6.
6. Kikkawa, R., Haneda, M., Kajiwara, N., Honde, N., Shigeta, Y. Aldose reductase inhibition prevents glucose-induced overproduction of type IV collagen in cultured mesangial cells. J Amer Soc Nephrol 1991, 2(3): 293.
7. Mizuno, K., Kato, N., Matsubara, A., Nakano, K., Kurono, M. Effects of a newaldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro[chroman - 4,4′ - imidazolidine] - 2 - carboxamide (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Metabolism 1992, 41: 1081-6.
8. Yamada, H., Hotta, N , Nakamura, J. et al. The preventive effect of aldose reductase inhibitor, SNK-860, on diabetic somatic and autonomic neuropathy in streptozotocin-induced diabetic rat. J Jpn Diabetes Soc 1993, 36 693-700.
9. Akita, M., Mizuno, K., Matsubara, A., Nakano, K., Kurono, M. Effects of an aldose reductase inhibitor, SNK-860, on the histopathological changes of refinal tissues in a streptozotocin-induced diabetic rat model. Acta Med Okayama 1993, 47: 299-304.
10. Kato, N., Mizuno, K., Matsubara, A., Nakano, K., Kurono, M., Yagihashi, S. Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro-[chroman-4,4′-imidazolidine] -2 -carboxamide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats. J Diabetes Complications 1994, 8: 27-32.
11. Sawai, K., Kuroni, M., Nakano, K., Sato, M., Kuboyama, N., Ito, T., Kondo, Y. (Sanwa Kagaku Kenkyusho Co., Ltd.) Compsns containing aldose reductase inhibitors for the treatment of ulcers. EP 437025.
12. Sanwa Kagaku Kenkyusho Co , Ltd. Company Brochure 1995, March.
13. Castaner, J., Prous, J. AD-5467. Drugs Fut 1991, 16: 13-5.
14. Malamas, M.S., Hohman, T.C. ARI-509. Drugs Fut 1994, 19: 442-5.
15. Castañer, J., Prous, J. CT-112. Drugs Fut 1991, 16: 895-8.
16. Castañer, J., Prous, J. Epalrestat. Drugs Fut 1987, 12: 336-40.
17. M-16209. Annu Drug Data Report 1991, 13: 406.
18. SNK-860. Annu Drug Data Report 1993, 15: 748.
19. Castañer, J., Prous, J. Tolrestat. Drugs Fut 1984, 9: 670-2.
20. WP-921. Annu Drug Data Report 1994, 16: 559.
21. Castañer, J., Prous, J. Zenarestat. Drugs Fut 1989, 14: 26-8.
22. Prous, J., Mealy, N., Castañer, J. Zopolrestat. Drugs Fut 1995, 20: 33-6.
23. Kaino, R , Yamaguchi, T., Usui, T., Fukushima, M., Mizuno, K., Baba, Y., Kurono, M. Study on the synthesis of aldose reductase inhibitors (No. 5). Synthesis and activity of optically active hydantoin derivatives. 113th Annu Meet Pharmaceut Soc Jpn (March 29-31, Osaka) 1993, Abst 30CC 11-3.
24. Yamaguchi, T., Tomiya, N., Awaya, T., Kurono, M. Sample method for the determination of aldose reductase and activity of the new inhibitory agent SNK-860. 111th Annu Meet Pharmaceut Soc Jpn (March 28-30, Tokyo) 1991, Abst 29V 3-046.
25. Yamada, H., Honta, Y., Ko, N , Sakakibara, F., Nakamura, J., Komori, T., Mori, K., Naruse, K., Nakajima, E., Sakamoto, N. Effect of a new AR inhibitor SNK-860 on autonomic nervous system diseases in STZ diabetic rats. J Jpn Diabetes Soc 1992, 35(Suppl.1): Abst H 220.
26. Horita, Y., Tsunoda, H., Fukazawa, H., Ko, N., Sakakibara, F., Sakamoto, N., Mizuno, K., Kato, N., Kurono, M Effect of a novel AR inhibitor, SNK-860 and tisssue selectivity - Comparison with MNCV and ERG. J Jpn Diabetes Soc 1991, 34(Suppl. 1): Abst G 313.
27. Kato, N., Matsubara, A., Mizuno, K., Nakano, M , Kurono, M., Yagihashi, S. Effect of continuous long-term administration of a novel aldose reductase inhibitor, SNK-860 on autonomic nervous system injury in experimentally induced diabetes in rats. J Jpn Diabetes Soc 1991, 34(Suppl. 1): Abst P3 250.
28. Asahina, T., Kashiwagi, A., Ikebuchi, M , Kida, Y., Ogawa, T., Tanaka, Y., Kikkawa, R., Shigeta, Y Impairment of peroxidase-dependent degradation of hydrogen peroxide and cell injury in endothelial cells cultured in high glucose media. J Jpn Diabetes Soc 1991, 34: 593-8.
29. Mizuno, K., Tokunaga, T., Nagano, H., Suzuki, T. Effects of AR inhibitor (SNK-860) on platelet aggregation acceleration and decline in erythrocyte transformation in rabbits with diabetes. J Jpn Diabetes Soc 1995, 38(Suppl. 1): 303.